I would actually argue that the chances of using it are actually much higher & it would make the top 1000 options in terms of expected ROI. Using type 1 diabetes as an example:
By age 18, approximately 1/300 people in the US develop type 1 diabetes
and that's just for diabetes. Consider the chances and corresponding research around cerebral palsy, hair loss, heart failure, liver disease, cancers, and more that stem cells - and specifically cord blood stem cells - have been successfully used for.
I would actually argue that the chances of using it are actually much higher & it would make the top 1000 options in terms of expected ROI. Using type 1 diabetes as an example:
By age 18, approximately 1/300 people in the US develop type 1 diabetes
https://www.medicalnewstoday.com/articles/240160#1 -> here's an article demonstrating how cord blood has successfully reversed type 1 diabetes
and that's just for diabetes. Consider the chances and corresponding research around cerebral palsy, hair loss, heart failure, liver disease, cancers, and more that stem cells - and specifically cord blood stem cells - have been successfully used for.